CHINA XLX FERTILISER LTD. 中國心連心化肥有限公司 * Should you have any queries relating to the content of this letter, please call the telephone hotline of the Hong Kong Share Registrar at (852) 2980 1333 during business hours (9:00 a.m. to 5:00 p.m. from Monday to Friday, excluding public holidays) or send an email to chinaxlx-ecom@hk.tricorglobal.com. (Incorporated in Singapore with limited liability) （ 在 新 加 坡 註 冊 成 立 之 有 限 公 司 ） (Hong Kong Stock Code╱香港股份代號 : 1866) NOTIFICATION LETTER 通知信函 6 November 2024 Dear Non ...

CHINA XLX FERTILISER LTD. 中國心連心化肥有限公司 * China XLX Fertiliser Ltd. (the "Company") Notice of Publication of Circular, Notice of Extraordinary General Meeting and Proxy Form ("Current Corporate Communication") The English and Chinese versions of the Company's Current Corporate Communication are available on the Company's website at www.chinaxlx.com.hk and the website of The Stock Exchange of Hong Kong Limited (the "Stock Exchange") at www.hkexnews.hk, or the printed form of Current Corporate Communication are ...

* 1866 股東特別大會通告 茲通告中國心連心化肥有限公司（「本公司」）謹訂於二零二四年十一月二十九日下午二時 假座中國河南省新鄉經濟開發區心連心大道七號門研發樓六樓第二會議室舉行二零二四 年第三次股東特別大會（「大會」或「股東特別大會」），以考慮及酌情通過下列決議案（不論 有否修訂）為本公司之普通決議案： 本股東特別大會通告中所有未曾界定的詞彙與本公司日期為二零二四年十一月六日的股 東通函（「通函」）中所賦予的含義相同。 香港交易及結算所有限公司及香港聯合交易所有限公司對本通告的內容概不負責，對其 準確性或完整性亦不發表任何聲明，並明確表示，概不對因本通告全部或任何部份內容 而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 CHINA XLX FERTILISER LTD. 承董事會命 中國心連心化肥有限公司 主席 劉興旭 普通決議案 - 1 - 1. 考慮及批准本公司日期為二零二四年十一月六日的通函所載第8項決議案的建議修 訂，內容有關於二零二四年五月十七日舉行的本公司股東週年大會上授予董事會回 購本公司股份的一般授權。 2. 考慮及批准本公司日期為二零二四年十一月六日的通函所載第9項決議案的建議修 ...

倘 閣下未能親身出席股東特別大會，務請儘早將隨附的代表委任表格按其上印列的指示填妥 及簽署，並交回本公司的香港股份過戶登記分處卓佳證券登記有限公司，地址為香港夏愨道16 號遠東金融中心17樓，惟無論如何須於股東特別大會或其任何續會指定舉行時間四十八小時前 交回（即不遲於二零二四年十一月二十七日下午二時。股東填妥及交回代表委任表格後，仍可 依願親身出席股東特別大會，並於會上投票。 此乃要件 請即處理 二零二四年十一月六日 閣下如對本通函任何方面或應採取之行動有任何疑問，應諮詢 閣下的股票經紀、持牌證券交 易商、銀行經理、律師、專業會計師或其他專業顧問。 閣下如已將名下中國心連心化肥有限公司股份全部售出或轉讓，應立即將本通函連同隨附的代 表委任表格送交買主或承讓人或經手買賣或轉讓的銀行、持牌證券交易商或證券註冊機構或其 他代理商，以便轉交買主或承讓人。 香港交易及結算所有限公司及香港聯合交易所有限公司對本通函的內容概不負責，對其準確性 或完整性亦不發表聲明，並明確表示，概不對因本通函全部或任何部分內容而產生或因倚賴該 等內容而引致的任何損失承擔任何責任。 CHINA XLX FERTILISER LTD. * 2 ...

Investment Rating - The report maintains a "Buy" rating for China Heart and Heart Fertilizer with a target price of HKD 6.5, indicating a potential upside of 55% from the current price of HKD 4.2 [4][3]. Core Insights - The company reported a revenue of RMB 17.42 billion for the first three quarters, a slight decrease of 0.6% year-on-year, while net profit attributable to shareholders increased by 80.7% year-on-year to RMB 1.53 billion, aligning with expectations [2][3]. - The strong profit growth is attributed to a decrease in raw material prices and stable production operations, leading to a 5% increase in gross profit [2]. - The company sold 100% equity in Tianxin Coal Industry, generating an investment income of RMB 790 million, with a total of RMB 800 million received by the end of the third quarter [2]. Revenue Breakdown - Urea revenue accounted for RMB 5.62 billion, representing 32% of total revenue, with a sales volume of 2.768 million tons, up 33% year-on-year, despite a 14% decline in average selling price to RMB 2029 per ton [3]. - Compound fertilizer revenue was RMB 4.65 billion, making up 27% of total revenue, with stable sales volume and a gross margin increase of 5 percentage points due to higher sales of efficient fertilizers [3]. - Methanol revenue reached RMB 1.89 billion, contributing 11% to total revenue, with a 2% increase in average selling price and a 17% rise in sales volume [3]. - The report anticipates a seasonal fluctuation in demand for compound fertilizers and a gradual stabilization of fertilizer prices due to supply constraints and recovering demand [3]. Financial Performance - The company achieved a gross margin of 30% for urea, 17% for compound fertilizers, and 8% for methanol, with notable improvements in profitability across various segments [3]. - The report projects a revenue growth rate of 4.1% for FY2024, with net profit expected to increase significantly by 73.4% [5][7].

Summary of Conference Call Records Company and Industry Overview - The company operates in the chemical industry, specifically focusing on fertilizer production, utilizing a circular economy approach to optimize its supply chain and reduce environmental pollution [1][2][3] - The company aims to become the most respected fertilizer enterprise in China, with major production bases located in Henan, Xinjiang, and Jiangxi [1][3] Key Points and Arguments Production Capacity and Strategy - Current total production capacity includes 3.9 million tons of urea and 4.15 million tons of compound fertilizer [1] - Future strategic planning includes expanding production bases in Guangxi and Xinjiang, aiming for a nationwide layout of large and small bases [1][3] - The company has achieved industry-leading scale and profitability, being one of the few domestic companies producing both urea and compound fertilizers at a large scale [1][3] Financial Performance - For the first three quarters of 2024, the company reported sales revenue of approximately RMB 17.42 billion, with net profit of about RMB 2.031 billion, a 75% year-on-year increase [4] - Urea sales volume reached 2.7684 million tons, a 33% increase year-on-year, with revenue from urea at approximately RMB 5.618 billion, a 15% increase [4][5] - The compound fertilizer segment saw a profit increase of 77%, with overall sales volume remaining stable at 1.7342 million tons [5] Market Dynamics and Pricing - Raw material prices have been declining, impacting product prices; however, the company has managed to maintain stable sales through increased production capacity and marketing efforts [4][5] - The company anticipates that the market for fertilizers will improve in 2024, driven by rising agricultural product prices and supportive government policies [10][11] Environmental and Technological Initiatives - The company emphasizes environmental protection and resource utilization, adhering to a green development philosophy [2][3] - Significant investments in technology and innovation have been made, including the establishment of a three-tier ESG governance structure [2] Competitive Advantages - The company has a low-cost and differentiated competitive advantage, supported by over 50 years of production management experience [3][7] - It is recognized as a benchmark enterprise for energy efficiency in the industry, with a 10% cost advantage over similar companies [7] Future Outlook - The company plans to enhance its product structure and expand its market share by focusing on high-consumption products and improving brand competitiveness [3][6] - The goal is to increase the proportion of high-efficiency fertilizers in total sales to 80% by 2027 [26] Additional Important Information - The company has established a unique marketing service system to provide comprehensive support to farmers, enhancing the adoption of high-efficiency fertilizers [9][26] - The company is actively pursuing international expansion while maintaining its focus on the fertilizer business [7][32] - Capital expenditures are projected to remain stable, with a focus on completing ongoing projects and potentially increasing dividends post-2024 [31][32] This summary encapsulates the key insights from the conference call, highlighting the company's strategic direction, financial performance, market dynamics, and future outlook in the chemical and fertilizer industry.

Investment Rating - The report maintains an "Outperform" rating for China XLX Fertiliser [1][7][19] Core Views - In the first three quarters of 2024, the company achieved a net profit attributable to shareholders of RMB 1.534 billion, representing an 80.7% year-on-year increase, while operating income was RMB 17.420 billion, down 0.6% year-on-year [1][4] - The growth in performance is attributed to a decline in costs leading to a 5% year-on-year increase in gross profit, alongside a stable production line that effectively reduced overall energy consumption, resulting in a gross margin increase to 19% [1][4] - The company has also seen significant sales increases in major products, with urea sales volume up 33% year-on-year and methanol sales volume up 17% year-on-year [5][6] Financial Performance Summary - For the first three quarters of 2024, the average price of urea was RMB 2,029 per tonne, down 14% year-on-year, with sales volume reaching 2.768 million tonnes [5] - The average price of compound fertiliser remained flat at RMB 2,679 per tonne, with sales volume stable at 1.734 million tonnes, while gross margin increased by 5% year-on-year to 17% [5] - The company expects EPS for 2024, 2025, and 2026 to be RMB 1.18, 1.28, and 1.42 respectively, with a target price of HKD 5.16 based on a PE of 4.02 for 2024 [7][19] Project Development - Ongoing projects include the Xinjiang paraformaldehyde project, expected to complete by the end of 2024, and the Jiangxi Jiujiang industry chain extension project, anticipated to commence operations in Q3 2025 [6][7] - The Zhundong project and Guangxi Base Big Project are also progressing as planned, with expected completion dates in 2025 and 2026 respectively [6][7]

Financial Performance - For the nine months ended September 30, 2024, the company's operating revenue was RMB 17,419,724 thousand, a decrease of 0.6% compared to the same period last year[1]. - Net profit for the same period increased significantly by 75.8% to RMB 2,031,307 thousand, with net profit attributable to shareholders of the parent company rising by 80.7% to RMB 1,534,087 thousand[1]. - Basic earnings per share rose by 85.3% to RMB 1.26, while the weighted average return on equity decreased by 2 percentage points to 17.65%[1]. Cost and Margin Analysis - The company achieved a gross profit growth of 5% due to reduced raw material prices and stable production operations, while management and financial expenses decreased by 2% and 13% respectively[2]. - Urea gross margin remained stable at 30% compared to the same period last year[7]. - Compound fertilizer gross margin increased by 5 percentage points to 17%, driven by an 11% increase in sales of high-efficiency compound fertilizers, particularly in Xinjiang[7]. - Methanol gross margin rose by 8 percentage points to 8% due to ongoing technological innovations that reduced costs by 6%[7]. - Melamine gross margin decreased by 4 percentage points to 30% due to a decline in selling prices[7]. - The pharmaceutical intermediates segment saw a 13 percentage point drop in gross margin to -3%, attributed to increased costs from immature technology in Xinjiang[7]. Asset and Equity Position - Total assets increased by 5.6% to RMB 30,780,414 thousand, and equity attributable to owners rose by 19.0% to RMB 12,501,326 thousand[2]. - The asset-liability ratio improved to 59.4%, a decrease of 4.5 percentage points from the previous year[2]. - The company received RMB 800 million from the sale of its 100% stake in Tianxin Coal Industry, which effectively reduced its asset-liability ratio[3]. Sales and Production Capacity - Urea sales volume increased by 33% to 2,768,000 tons, driven by expanded production capacity and recovery of production facilities[6]. - The average price of urea decreased by 14% to RMB 2,029 per ton due to falling raw material prices and market supply-demand factors[5]. - The pharmaceutical intermediate segment saw an 18% increase in average price to RMB 45,106 per ton, supported by an increase in sales of higher-priced products[5]. Project Developments - The Xinjiang project is expected to complete construction by the end of the year, with a production capacity of 60,000 tons of formaldehyde[8]. - The Jiangxi project is on track for completion in Q3 2025, with a total capacity of 600,000 tons of synthetic ammonia and 1.2 million tons of controlled-release fertilizer[8]. - The Guangxi base project is progressing as planned, with a capacity of 1.2 million tons of synthetic ammonia and 1 million tons of high-efficiency compound fertilizers[9]. Market Outlook - The company anticipates stable fertilizer prices due to seasonal demand and supply constraints in the winter[10]. - Long-term growth is expected as the company focuses on sustainable development and green low-carbon transformation, enhancing product differentiation and resource utilization[11].

Strategic Positioning and Development Principles - The company's strategic positioning includes adhering to the development strategy of "Fertiliser as foundation, fertiliser and chemical side by side" and the operating strategy of "low-cost and differentiation" [5] - The company aims to achieve high-efficiency, high-end, lean development in the Group as its core mission [5] - The company follows six development principles, including strategic positioning direction, customer orientation, pursuing excellence, pragmatic and highly efficient management, key capabilities enhancement, and preventing and controlling development risks [6][7] - The company is committed to becoming China's most respected fertiliser enterprise group [5] Company Overview and Governance - The company's headquarters is located in Xinxiang Economic Development Zone, Henan Province, PRC [10] - The company's stock code on the Hong Kong Stock Exchange is 1866 [10] - The company's corporate website is www.chinaxlx.com.hk [10] - The company's board includes executive directors and independent non-executive directors, with Liu Xingxu as the Chairman of the Board [8] - The company's auditor is Ernst & Young LLP, with Yong Kok Keong as the partner-in-charge [9] - The company's principal bankers include China Construction Bank, Agricultural Bank of China, Bank of China, Industrial & Commercial Bank of China, Bank of Communications, and HSBC [9] Financial Performance and Key Metrics - Total revenue increased by approximately RMB2 million or 0.02% from RMB12,059 million in 1H2023 to RMB12,061 million in 1H2024 [11] - Net profit increased by approximately RMB160 million or 21% from RMB778 million in 1H2023 to RMB938 million in 1H2024 [11] - Gross profit increased by 12% YoY due to declining raw material costs [11] - Revenue for 2024 remained stable at RMB 12,060,957 thousand, showing minimal growth compared to RMB 12,059,121 thousand in 2023 [101] - Gross profit increased to RMB 2,355,720 thousand in 2024, up from RMB 2,110,699 thousand in 2023, reflecting improved cost management [101] - Profit before tax rose to RMB 1,122,610 thousand in 2024, compared to RMB 925,758 thousand in 2023, indicating stronger operational performance [101] - Net profit attributable to owners of the parent increased to RMB 686,996 thousand in 2024 from RMB 546,194 thousand in 2023 [101] - Basic earnings per share grew to RMB 56.4 cents in 2024, up from RMB 44.8 cents in 2023 [101] - Total assets increased to RMB 31,283,035 thousand in 2024, compared to RMB 29,133,496 thousand in 2023, driven by growth in non-current assets [103] - Cash and cash equivalents significantly increased to RMB 2,014,075 thousand in 2024 from RMB 1,162,558 thousand in 2023, reflecting improved liquidity [103] - Total equity rose to RMB 11,676,254 thousand in 2024, up from RMB 10,510,998 thousand in 2023, indicating stronger financial health [105] - Non-current liabilities decreased slightly to RMB 8,131,009 thousand in 2024 from RMB 8,178,917 thousand in 2023, showing reduced long-term debt burden [105] - Retained profits grew to RMB 3,774,432 thousand in 2024, up from RMB 3,378,490 thousand in 2023, reflecting improved profitability [107] - Total equity increased to RMB 11,676,254,000 as of 30 June 2024, up from RMB 10,510,998,000 at the beginning of the year [109] - Profit for the period reached RMB 686,996,000, contributing to the overall equity growth [109] - Net cash flows generated from operating activities amounted to RMB 2,075,084,000 for the six months ended 30 June 2024 [111] - Cash and cash equivalents at the end of the year stood at RMB 2,014,075,000, a significant increase from RMB 1,162,558,000 at the beginning of the year [113] - The company received government grants totaling RMB 49,214,000 during the period [111] - Proceeds from disposal of property, plant, and equipment were RMB 814,550,000, a substantial increase from RMB 33,004,000 in the same period last year [111] - Dividends paid to non-controlling shareholders amounted to RMB 446,138,000 [111] - Loans and borrowings proceeds were RMB 4,892,178,000, slightly higher than the previous year's RMB 4,880,817,000 [111] - Repayments of loans and borrowings were RMB 4,029,744,000, a decrease from RMB 5,292,047,000 in the same period last year [111] Product Performance and Segment Analysis - Urea sales revenue increased by approximately RMB316 million or 9% from RMB3,518 million in 1H2023 to RMB3,834 million in 1H2024 [12] - Urea sales volume increased by 25% YoY, while average selling price decreased by 13% YoY [12] - Urea gross profit margin increased by 2 percentage points from 29% in 1H2023 to 31% in 1H2024 [12] - Urea production output increased by 24% YoY due to released production capacity [12] - Urea solution for vehicle sales revenue decreased by approximately RMB59 million or 26% from RMB225 million in 1H2023 to RMB166 million in 1H2024 [12] - Urea solution for vehicle gross profit margin decreased by 6 percentage points to 18% in 1H2024 [12] - Compound fertilisers revenue increased by RMB 202 million or 6% to RMB 3,410 million in 1H2024, driven by a 13% YoY increase in sales volume, partially offset by a 6% YoY decrease in average selling price [13] - Compound fertilisers gross profit margin rose by 6 percentage points to 18% in 1H2024, due to an 18% YoY decrease in potash procurement price and a 23% YoY increase in high-efficiency compound fertiliser sales [13] - Methanol revenue increased by RMB 314 million or 32% to RMB 1,291 million in 1H2024, driven by a 31% YoY increase in sales volume and a 1% YoY increase in average selling price [13] - Methanol gross profit margin improved by 10 percentage points to 8% in 1H2024, due to a 9% YoY decrease in average cost of sales [13] - Melamine revenue decreased by RMB 15 million or 4% to RMB 397 million in 1H2024, mainly due to a 6% YoY decrease in average selling price [14] - Melamine gross profit margin decreased by 6 percentage points to 30% in 1H2024, due to a 6% YoY decrease in average selling price [14] - DMF revenue increased by RMB 72 million or 14% to RMB 595 million in 1H2024, driven by a 31% YoY increase in sales volume, despite a 13% YoY decrease in average selling price [14] - DMF gross profit margin increased by 2 percentage points to 13% in 1H2024, due to a 15% YoY reduction in average cost through production technology innovation and equipment improvement [14] - Revenue from the medical intermediate segment decreased by RMB65 million (22%) YoY to RMB234 million in 1H2024, driven by a 33% YoY decline in sales volume [15] - Gross profit margin of the medical intermediate segment dropped by 17 percentage points to -1% in 1H2024 due to a 38% YoY increase in average production costs [15] - Other income, net increased by RMB22 million (24%) YoY to RMB112 million in 1H2024, primarily due to a RMB31 million rise in subsidy income [15] - The company operates in seven reportable segments: urea, urea solution for vehicles, compound fertilizer, methanol, melamine, DMF, and medical intermediates [122] - Total revenue for the six months ended 30 June 2024 was RMB 12,060,957,000, with urea contributing the largest share at RMB 3,834,000,000 [126] - Segment profit for the period was RMB 2,355,720,000, with urea generating the highest segment profit of RMB 1,181,231,000 [126] - Other products, including liquid ammonia, organic amines, humic acid, and furfuryl alcohol, contributed sales revenue of RMB 668 million, RMB 275 million, RMB 201 million, and RMB 163 million respectively [127] - Profit before tax for the period was RMB 1,122,610,000, with income tax expense of RMB 184,124,000, resulting in a net profit of RMB 938,486,000 [126] - Unallocated expenses for the period amounted to RMB 980,827,000, primarily consisting of other income, other expenses, selling and distribution expenses, general and administrative expenses, finance costs, and income tax expense [126] - Interest income for the period was RMB 13,714,000, while finance costs were RMB 265,997,000 [126] Expenses and Costs - Selling and distribution expenses rose by RMB67 million (22%) YoY to RMB378 million in 1H2024, driven by increased advertising and sales performance commissions [16] - General and administrative expenses increased by RMB62 million (9.7%) YoY to RMB702 million in 1H2024, mainly due to higher management salaries and service fees [16] - Finance costs decreased by RMB58 million (18%) YoY to RMB266 million in 1H2024, supported by lower interest rates and early repayment of high-interest borrowings [18] - Employee benefit expenses, including salaries and bonuses, rose to RMB 1,221,372 thousand in 2024 from RMB 1,076,976 thousand in 2023 [145] Market and Industry Outlook - The company expects compound fertilizers to perform better in 2H2024, with industrial demand for urea significantly increasing due to national policy requirements [24] - Domestic economic recovery is expected to improve in the second half of the year, with stable coal prices and balanced supply and demand in the fertilizer industry [27] - Urea demand is projected to increase significantly due to government-mandated urea denitrification upgrades in the power sector [27] - The company is leveraging big data and transforming its sales structure to focus on large-scale farmers, enhancing brand influence through differentiated products and precision services [27] - The company is strengthening technical upgrades and investing in advanced technologies to maximize investment returns [27] - Domestic policy adjustments have led to a significant increase in volume, impacting overall cash flow [27] Shareholder and Equity Information - Ms. Yan Yunhua holds 21.18% of the company's issued shares, with 257,166,000 shares in total [31] - Pioneer Top Holdings Limited holds 35.11% of the company's issued shares, with 426,344,999 shares [35] - Mirth Power Limited holds 17.45% of the company's issued shares, with 211,939,848 shares [35] - The Share Award Plan is valid for 10 years from 17 May 2024, with a grant price of HK$1.5 per share [61][64] - 70,790,000 awards were granted under the Share Award Plan during the reporting period, representing approximately 5.83% of the company's issued share capital [69] - The maximum number of shares subject to awards in a 12-month period shall not exceed 1% of the relevant class of shares in issue [69] - The aggregate maximum number of shares under the Share Award Plan and other share schemes shall not exceed 10% of the total issued shares as of the adoption date (121,768,000 shares) [67][68] - The first vesting period allows 50% of the awarded shares to be vested, while the second vesting period allows the remaining 50% [66] - The minimum holding period for an award before vesting is 12 months, but the board may determine a shorter period at its discretion [66] - The number of share awards available for grant under the Share Award Plan at the end of the reporting period was 50,978,000 [70][71] - During the reporting period, 70,790,000 share awards were granted under the Share Award Plan, representing approximately 5.83% of the company's issued share capital [70] - The ratio of shares issued for options and awards granted during the reporting period to the weighted average number of shares (excluding treasury shares) was 5.81% [70][71] - On 7 June 2024, 15,540,000 shares were awarded to connected persons of the company (excluding directors, chief executives, or substantial shareholders) [74] - A total of 51,140,000 shares were awarded to other selected participants on 7 June 2024 [75] - The share closing price on the date of grant (7 June 2024) was HK$3.86 per share [74][75] - The company repurchased 4,336,000 issued shares through the SEHK spot market at a total consideration of approximately HK$17,316,000, representing 0.36% of the issued shares as of 30 June 2024 [84][85] - The repurchased shares were canceled on 18 June 2024, with the purchase price per share ranging from HK$3.795 to HK$4.15 [84][86] - The share repurchase was based on the company's confidence in its long-term business prospects and potential growth, aiming to optimize the capital structure and improve earnings per share, net assets per share, and overall shareholder returns [84][85] - No equity-linked agreements were entered into by the company during the reporting period, except for the disclosed Share Award Plan [77][79] - The company confirmed compliance with the Model Code for Securities Transactions by Directors of Listed Issuers during the six months ended 30 June 2024 [81][83] - No incidents of non-compliance with the Employees Written Guidelines for securities transactions were noted during the reporting period [82][83] - The company did not hold any treasury shares as of 30 June 2024, and no other listed securities were purchased, sold, or redeemed during the period [87] Debt and Liquidity Management - The Group's debt maturing in less than one year as of 30 June 2024 is approximately RMB 5,020,000,000, representing 41.10% of total debts, compared to RMB 4,468,625,000 (38.41%) as of 31 December 2023 [50] - The gearing ratio (total debt divided by total assets) as of 30 June 2024 is 62.7%, a decrease of 1.3 percentage points compared to 31 December 2023 [52] - The Group's revenue and costs are primarily denominated in RMB, with some costs in HKD, USD, or SGD [45] - The consumer price index in China increased by 0.1% YoY for the six months ended 30 June 2024, with no significant impact on the Group's operating results [46] - The Group has no material contingent liabilities or significant litigation/arbitration as of 30 June 2024 [53][54] - No significant investments were made during the six months ended 30 June 2024 [56] - The Group is exposed to market risks including changes in product selling prices, raw material costs (mainly coal), and fluctuations in interest and exchange rates [42] - Commodity price risk arises from fluctuations in product sale prices and raw material costs [43] - Interest rate risk is primarily related to the Group's long-term debt obligations subject to floating rates [44] - The Group monitors liquidity risk by balancing funding continuity and flexibility through bank overdrafts and loans [50] - The Group's debt-to-asset ratio decreased to 62.7% as of the first half of 2024, down by 1.3 percentage points from 64% at the end of 2023 [174][176] - Total interest-bearing bank and other borrowings amounted to RMB 12,213,223,000 as of 30 June 2024, compared to RMB 11,633,132,000 at the end of 2023 [171] - Secured bank loans totaled RMB 1,528,279,000, secured by the Group's property, plant, and equipment [172] - Interest expenses capitalized to property, plant, and equipment during the period were RMB 4,070,000, a significant decrease from RMB 13,322,000 in the same period of 2023 [175][176] - Bank loans repayable within one year or on demand increased to RMB 4,731,317,000 as of 30 June 2024, up from RMB 4,088,482,000 at the end of 2023 [171] Investments and Disposals - Xinjiang XLX Energy Chemicals Co., Ltd. disposed of 100% equity interests in Manas Tianxin Coal CO., LTD for a total consideration of approximately RMB1,374 million [88][90] - No significant investments were made during the six months ended 30 June 2024 [56] - The company has no plans for material investments or capital assets as of 30 June 2024 [60] Employee and Training Information - The Group had 10,781 employees as of 30 June 2024, an increase from 10,390 employees as of 31 December 2023 [92][95] - Marketing personnel's performance commissions and bonuses decreased due to the decline in performance this year [92][95] - The Group provides ongoing training for all employees, including Directors and senior management, tailored to their specific fields of operation [92][95] - No significant events affecting the Group have occurred since the end of the reporting period [93][96] Dividend and Shareholder Returns - The company proposed a final dividend of RMB 0.24 per ordinary share for the year ended 31 December 2023, totaling approximately RMB 292,503 thousand, but did not declare any interim dividend for 2024 [150] - The final dividend for the year ended December 31, 2023, is RMB 0.24 per ordinary share, totaling approximately RMB 292,503,000, compared to RMB 307,030,000 for the year ended December 31, 2022 [152] Financial Reporting and Standards - The

Investment Rating - The report assigns a "Buy" rating for the company with a target price of 6.5 HKD, indicating an 83% upside potential from the current price of 3.6 HKD [3][2]. Core Insights - The company achieved a 26% year-on-year growth in net profit for the first half of 2024, exceeding expectations, despite a decline in fertilizer and fine chemical product prices [2][1]. - The strong cost advantage of the company allows it to maintain high profitability even during a downturn in urea prices [2][1]. - The increase in sales volume of efficient fertilizers contributes to an improvement in profit margins [2]. Financial Performance Summary - Revenue for the first half of 2024 reached 12.06 billion RMB, remaining flat year-on-year, while net profit attributable to shareholders was 690 million RMB, up 26% [2]. - Urea revenue was 3.83 billion RMB, a 9% increase year-on-year, with a 13% price decline but a 25% increase in sales volume, leading to a 2 percentage point increase in gross margin to 31% [2]. - Compound fertilizer revenue was 3.41 billion RMB, a 6% increase year-on-year, with a 6% price decline and a 13% increase in sales volume, resulting in a 6 percentage point increase in gross margin to 18% [2]. - The chemical business continues to expand, with methanol revenue increasing by 32% year-on-year to 1.29 billion RMB, and DMF revenue growing by 14% to 600 million RMB [2]. Future Outlook - The company is expected to experience a peak in capital expenditures from 2024 to 2026, with several new projects set to commence production, including a compound fertilizer project in Huludao and a 60,000-ton polyformaldehyde project in Xinjiang [2]. - To alleviate financial pressure and focus on its core business, the company has sold its 100% stake in Xinjiang Tianxin Coal Mine for 1.37 billion RMB, providing a one-time income boost [2].